← FDA Drug Approvals (Drugs@FDA)
DOXEPIN HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: UNIQUE · Approved 2023-08-21
Drug application
- FDA Application #
ANDA217975- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DOXEPIN HYDROCHLORIDE
- Generic name
- DOXEPIN HYDROCHLORIDE
- Active ingredients
- DOXEPIN HYDROCHLORIDE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- UNIQUE
- Manufacturer
- Rising Pharma Holdings, Inc.
- First approval
- 2023-08-21
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown